| scholarly article | Q13442814 |
| P356 | DOI | 10.1081/CNV-200027141 |
| P698 | PubMed publication ID | 15565816 |
| P2093 | author name string | Howard A Fine | |
| Benjamin Purow | |||
| P2860 | cites work | Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity | Q24561642 |
| Vascular-specific growth factors and blood vessel formation | Q29614780 | ||
| Mechanisms of angiogenesis and arteriogenesis | Q29617257 | ||
| Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data | Q30625695 | ||
| Continuous release of endostatin from microencapsulated engineered cells for tumor therapy | Q31793485 | ||
| Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model | Q32145219 | ||
| Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991 | Q32157803 | ||
| Antitumor activity of thalidomide in refractory multiple myeloma | Q33880642 | ||
| Mechanism of action in thalidomide teratogenesis | Q33900903 | ||
| Local endostatin treatment of gliomas administered by microencapsulated producer cells | Q33929689 | ||
| Descriptive analysis and quantification of angiogenesis in human brain tumors | Q34178854 | ||
| Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas | Q34344877 | ||
| Induction of angiogenesis during the transition from hyperplasia to neoplasia | Q34413571 | ||
| Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases. | Q34756781 | ||
| Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption | Q34997337 | ||
| Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer | Q35279932 | ||
| The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. | Q36598768 | ||
| Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents | Q36674977 | ||
| Organ targeting in vivo using phage display peptide libraries | Q36795550 | ||
| Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis | Q37379687 | ||
| The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat. | Q39519719 | ||
| Tumor invasion, proteolysis, and angiogenesis | Q40394594 | ||
| Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer | Q40608619 | ||
| A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer | Q40704741 | ||
| Combined treatment of a murine breast cancer model with type 5 adenovirus vectors expressing murine angiostatin and IL-12: a role for combined anti-angiogenesis and immunotherapy | Q40807329 | ||
| Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13). | Q40844552 | ||
| Inhibition of angiogenesis in vivo by interleukin 12. | Q41665801 | ||
| Non-invasive vascular imaging: assessing tumour vascularity | Q41756158 | ||
| Therapeutic effects of viral vector-mediated antiangiogenic gene transfer in malignant ascites | Q43740110 | ||
| Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach | Q43758687 | ||
| Tumor regression by targeted gene delivery to the neovasculature | Q44044889 | ||
| Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. | Q44393459 | ||
| Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice | Q45858195 | ||
| Combined effects of angiostatin and ionizing radiation in antitumour therapy | Q47762838 | ||
| Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. | Q47822182 | ||
| Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas | Q48748937 | ||
| Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth | Q48752349 | ||
| High microvessel density in primitive neuroectodermal brain tumors of childhood | Q48837314 | ||
| Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance | Q50626711 | ||
| Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a | Q54093950 | ||
| Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. | Q55476886 | ||
| Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. | Q55477127 | ||
| P433 | issue | 4 | |
| P921 | main subject | angiogenesis inhibitor | Q574834 |
| P304 | page(s) | 577-587 | |
| P577 | publication date | 2004-01-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Cancer Investigation | Q325953 |
| P1476 | title | Progress report on the potential of angiogenesis inhibitors for neuro-oncology | |
| P478 | volume | 22 |
| Q30828938 | A novel three-dimensional system to study interactions between endothelial cells and neural cells of the developing central nervous system |
| Q36642793 | AAV-mediated gene transfer of human pigment epithelium-derived factor inhibits Lewis lung carcinoma growth in mice |
| Q36887534 | Angiogenesis in brain tumours |
| Q36272985 | Anti-angiogenic therapy in pediatric neuro-oncology. |
| Q36764016 | Emerging monoclonal antibody therapies for malignant gliomas |
| Q40252978 | Gene transfer of pigment epithelium-derived factor suppresses tumor growth and angiogenesis in a hepatoblastoma xenograft model |
| Q37018652 | Mechanisms of disease: the PI3K-Akt-PTEN signaling node--an intercept point for the control of angiogenesis in brain tumors |
| Q35609031 | mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine |
Search more.